Activity of oral agents against pediatric isolates of Streptococcus pneumoniae

被引：3
|
作者：
Black, J
Moland, ES
Chartrand, SA
Thomson, KS
机构：
[1] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Ctr Res Anti Infect & Biotechnol, Omaha, NE 68178 USA
[2] Creighton Univ, Sch Med, Dept Pediat Infect Dis, Omaha, NE 68178 USA
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2001年 / 39卷 / 03期
关键词：
D O I：
10.1016/S0732-8893(01)00209-7
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
An in vitro study of the activity of 10 oral agents against 153 pediatric isolates of Streptococcus pneumoniae identified moxifloxacin and levofloxacin as the most active agents regardless of penicillin or macrolide susceptibility. Moxifloxacin inhibited all strains at 0.25 mug/ml and was 8- to 16-fold more potent than levofloxacin. (C) 2001 Elsevier Science inc. All rights reserved.
引用
收藏
页码：195 / 197
页数：3
相关论文
共 50 条
  • [31] In Vitro Activity of Delafloxacin Tested against Isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Flamm, Robert K.
    Rhomberg, Paul R.
    Huband, Michael D.
    Farrell, David J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (10) : 6381 - 6385
  • [32] Antimicrobial activity and spectrum of sparfloxacin tested against erythromycin-resistant Streptococcus pneumoniae isolates
    Barrett, MS
    Jones, RN
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1996, 24 (02) : 113 - 116
  • [33] In vitro activity of delafloxacin against highly levofloxacin-resistant invasive isolates of Streptococcus pneumoniae
    Cercenado, Emilia
    Loras, Cristina
    Cobos, Alejandro
    Sanz, Juan Carlos
    ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2022, 40 (03): : 131 - 133
  • [34] In Vitro Activity of Ceftaroline against Streptococcus pneumoniae Isolates Exhibiting Resistance to Penicillin, Amoxicillin, and Cefotaxime
    Fenoll, Asuncion
    Aguilar, Lorenzo
    Robledo, Olga
    Gimenez, Maria-Jose
    Granizo, Juan-Jose
    Biek, Donald
    Tarrago, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (11) : 4209 - 4210
  • [35] Activity of gemifloxacin against invasive and multi-resistant Streptococcus pneumoniae isolates collected in the UK
    Johnson, AP
    Warner, M
    Nguyen-Van-Tam, JS
    Livermore, DM
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (01) : 188 - 189
  • [36] In vitro activity of telithromycin against Spanish Streptococcus pneumoniae isolates with characterized macrolide resistance mechanisms
    Morosini, MI
    Cantón, R
    Loza, E
    Negri, MC
    Galán, JC
    Almaraz, F
    Baquero, F
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (09) : 2427 - 2431
  • [37] In Vitro Evaluation of the Antimicrobial Activity of Ceftaroline against Cephalosporin-Resistant Isolates of Streptococcus pneumoniae
    Mcgee, Lesley
    Biek, Donald
    Ge, Yigong
    Klugman, Magderie
    du Plessis, Mignon
    Smith, Anthony M.
    Beall, Bernard
    Whitney, Cynthia G.
    Klugman, Keith P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2009, 53 (02) : 552 - 556
  • [38] Dual activity of fluoroquinolones against Streptococcus pneumoniae
    Fisher, LM
    Heaton, VJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (02) : 463 - 464A
  • [39] DOXYCYCLINE ACTIVITY AGAINST STREPTOCOCCUS-PNEUMONIAE
    SHEA, KW
    CUNHA, BA
    UENO, Y
    ABUMUSTAFA, F
    QADRI, SMH
    CHEST, 1995, 108 (06) : 1775 - 1776
  • [40] Activity of oral β-lactam antimicrobial agents versus respiratory tract isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the era of antibiotic resistance
    Doern, GV
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2002, 127 (06) : S17 - S23
12345